Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Efrat Kurtzwald-Josefson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Heart Rhythm|March 25, 2017
Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse modelsEfrat Kurtzwald-Josefson, Dor Yadin, Shiraz Harun-Khun, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 9, 2012
Exercise training improves cardiac function and attenuates arrhythmia in CPVT miceEfrat Kurtzwald-Josefson, Edith Hochhauser, Guy Katz, et al.
International Journal of Molecular Sciences|October 28, 2023
Ubiquitin Proteasome System Role in Diabetes-Induced CardiomyopathyOrtal Nahum-Ankonina, Efrat Kurtzwald-Josefson, Aaron Ciechanover, et al.
Heart Rhythm|April 29, 2014
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant miceEfrat Kurtzwald-Josefson, Edith Hochhauser, Katia Bogachenko, et al.
International Journal of Molecular Sciences|October 2, 2020
Cardiac Fibroblast-Induced Pluripotent Stem Cell-Derived Exosomes as a Potential Therapeutic Mean for Heart FailureEfrat Kurtzwald-Josefson, Naama Zeevi-Levin, Victor Rubchevsky, et al.
Biochemical Pharmacology|September 28, 2013
The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2)Guy Katz, Asher Shainberg, Edith Hochhauser, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Heart Rhythm|March 25, 2017
Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse modelsEfrat Kurtzwald-Josefson, Dor Yadin, Shiraz Harun-Khun, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 9, 2012
Exercise training improves cardiac function and attenuates arrhythmia in CPVT miceEfrat Kurtzwald-Josefson, Edith Hochhauser, Guy Katz, et al.
International Journal of Molecular Sciences|October 28, 2023
Ubiquitin Proteasome System Role in Diabetes-Induced CardiomyopathyOrtal Nahum-Ankonina, Efrat Kurtzwald-Josefson, Aaron Ciechanover, et al.
Heart Rhythm|April 29, 2014
Alpha blockade potentiates CPVT therapy in calsequestrin-mutant miceEfrat Kurtzwald-Josefson, Edith Hochhauser, Katia Bogachenko, et al.
International Journal of Molecular Sciences|October 2, 2020
Cardiac Fibroblast-Induced Pluripotent Stem Cell-Derived Exosomes as a Potential Therapeutic Mean for Heart FailureEfrat Kurtzwald-Josefson, Naama Zeevi-Levin, Victor Rubchevsky, et al.
Biochemical Pharmacology|September 28, 2013
The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2)Guy Katz, Asher Shainberg, Edith Hochhauser, et al.
Pageof 1